DRUG · Unmapped registry intervention
F-18 RGD-K5
Find medicine records ·
Find other trials using this name
Clinical trial
Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
NCT00743353
Study summary
ClinicalTrials.govExploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Sarcomaverified · MONDO: sarcoma
Melanomaverified · MONDO: melanoma
Lung Cancerverified · MONDO: lung cancer
Breast Cancerverified · MONDO: breast cancer
High Grade Gliomasunresolved
Interventions
F-18 RGD-K5DRUG
Sponsors & collaborators
Siemens Molecular Imaginglead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00743353 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.